Showing results (661-670 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|September 5, 2021
Identifying adults at high-risk for change in weight and BMI in England: a longitudinal, large-scale, population-based cohort study using electronic health recordsMichail Katsoulis, Alvina G Lai, Karla Diaz-Ordaz, et al.
The Lancet. Diabetes & Endocrinology|December 11, 2025
Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technologyKetan Dhatariya, Richard M Bergenstal, Mohammed Al-Sofiani, et al.
The Lancet. Diabetes & Endocrinology|December 21, 2025
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trialFrederick J Raal, Jean Bergeron, Daniel Gaudet, et al.
The Lancet. Diabetes & Endocrinology|January 30, 2026
Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trialAlbert Wiegman, Amy L Peterson, Eric Bruckert, et al.
The Lancet. Diabetes & Endocrinology|November 17, 2025
Comorbidities and mortality in subgroups of adults with diabetes with up to 14 years follow-up: a prospective cohort study in SwedenOlof Asplund, Manonanthini Thangam, Rashmi B Prasad, et al.
The Lancet. Diabetes & Endocrinology|June 24, 2025
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialLinong Ji, Leili Gao, Haibo Xue, et al.
The Lancet. Diabetes & Endocrinology|September 17, 2025
Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trialSean Wharton, Paula Freitas, Jøran Hjelmesæth, et al.
The Lancet. Diabetes & Endocrinology|May 5, 2025
Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and managementWilmar M Wiersinga, Anja K Eckstein, Miloš Žarković
The Lancet. Diabetes & Endocrinology|November 9, 2025
Time trends in mortality from heart failure and atherosclerotic cardiovascular disease in people with and without diabetes: a multi-national population-based studyJoanna Y Gong, Jedidiah I Morton, Lei Chen, et al.
The Lancet. Diabetes & Endocrinology|October 2, 2025
Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trialFilip K Knop, George Kunos, Dror Dicker, et al.
Pageof 93